Metabolize Raises $3.2M in Seed Funding
Metabolize, a San Francisco-based company focused on metabolic health, has secured $3.2 million in seed funding led by Astanor. The startup utilizes research from Stanford Medicine to develop non-prescription solutions designed to support appetite regulation and weight management for individuals transitioning off GLP-1 therapies.
HNH Insight
This funding highlights the growing intersection of metabolic health technology and the 'food as medicine' movement, specifically targeting the post-GLP-1 market with precision nutrition solutions.
Exchange Discussion
Join the expert conversation on this article in the HN&H Intelligence Exchange. Professional discussion only — cite your sources.
No comments yet.
